The main objective of my research is to develop advanced in vitro models of angiogenesis, with a particular focus on vascularized breast tumor-on-chip platforms. Tumor-induced vascularization plays a key role in disease progression, metastasis, and therapeutic response, making it a critical target for translational research.
My approach aims to achieve a balance between biological fidelity and methodological simplicity, enabling the systematic investigation of tumor–vascular interactions while maintaining experimental robustness and reproducibility. By integrating microfluidic engineering with vascular and tumor biology, I seek to develop physiologically relevant models with enhanced predictive power compared to existing platforms.
I believe that accurate modeling of angiogenesis using microfluidic platforms may ultimately represent a significant advance in cancer research, supporting the development of more effective, targeted, and personalized therapeutic strategies.